6-methoxy-3-(prop-2-yn-1-yl)benzo[d]thiazol-2(3H)-imine hydrobromide, 95.0%, 500mg

2-(4-((2-Chlorothiazol-5-yl)methoxy)phenyl)acetonitrile, 95+%, 1g

4-Bromo-m-xylene, 98.0%, 500g

4-(4-Methyl-piperazin-1-ylmethyl)-phenylamine, 95.0%, 1g

(S)-tert-Butyl 1-(3-fluorobenzoyl)pyrrolidin-3-ylcarbamate, 95.0%, 1g

Cyanomethyl 4-methylbenzenesulfonate, 95.0%, 100g

1-Methylcyclohexanol, 95.0%, 5g

N-(5-Bromothiazol-2-yl) acetamide hydrobromide, 95.0%, 5g

Objetivo E-plan EPL S40x/0,65. Distancia de trabajo 0,64 mm

(11bR)-2,6-Bis(4-chlorophenyl)-4-hydroxydinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepine 4-oxide, 97%, 50mg

Cuba de muestra Tipo 2118, 250 ml, 6 Unidad(es)

5-Nitroacenaphthene (contains 3-Nitroacenaphthene)>80.0%(GC)5g

2-(3-oxocyclobutyl)acetonitrile, 95.0%, 5g